Agalsidase beta 5mg powder for solution for infusion vials

ID
41758111000001109
Date
9 May 2023
Previous ID
413468006
Therapeutic Moiety
Agalsidase beta
Name
Agalsidase beta 5mg powder for solution for infusion vials
Preferred name basis
rINN - Recommended International Non-proprietary
Date of name applicability
13 Jan 2009
Previous name
Agalsidase beta 5mg powder for solution for injection vials
Basis of previous name
rINN - Recommended International Non-proprietary
Reason for name change
Other
Prescribing status
Valid as a prescribable product
Dose form
Discrete
Unit dose form size
1.000
Unit dose form units
vial
Unit dose unit of measure
vial
Ingredients
Agalsidase beta
Form & Route
solutioninfusion.intravenous
Drug formulations
Powder for solution for infusion
Drug route
Intravenous
Control drug
No Controlled Drug Status